{"id":15736,"date":"2014-02-21T09:05:37","date_gmt":"2014-02-21T14:05:37","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=15736"},"modified":"2014-02-21T07:11:26","modified_gmt":"2014-02-21T12:11:26","slug":"stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736","title":{"rendered":"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 02\/20\/2014 (wallstreetpr) &#8211;\u00a0<b>Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)<\/b> could soon be without the services of its billionaire chairman Philip Frost if reports appearing on the media are true. It is reported that the entrepreneur might leave the Israel-based TEVA before his current terms expires next year. However, some other reports say that Mr. Frost has not set the actual date for his exit at TEVA. Perhaps investors need to know that the 77-year old businessman also holds two chairman positions in <b>Ladenburg Thalmann Financial Services (NYSE:LTS) <\/b>and<b> Opko Health (NYSE:OPK)<\/b>. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) was last seen with $1.75 gain per share to settle at $48.20.<\/p>\n<p style=\"text-align: justify;\"><b>Oi SA (ADR) (NYSE:OIBR)<\/b> stock was last seen with more than 1.9 percent gain to $1.60 per share, after the company announced an ambitious plan to raise roughly $5.9 billion in shares offering. This stock offering plan was revealed in regulatory filing Thursday. The company needs money to tool up its operations and more so for the proposed merger with Portugal Telecom. OIBR and Portugal Telecom announced plans to join forces in October last year and they hope that the move will result into a new company boasting more than 100 million subscribers. Also, the resulting company is hoped would be able to generate excess of $19 billion in annual revenue. More importantly, the two telecoms companies teaming up in a merger will enable them to compete effectively against bigger rivals America Movil and <b>Telefonica S.A. (ADR) (NYSE:TEF)<\/b>.<\/p>\n<p style=\"text-align: justify;\"><b>Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) <\/b>shareholders seem to be excited by reports that one of the company\u2019s biggest investors is vying to get two board seats. The investor in question is Sarissa Capital Management which is low the second largest shareholder in ARIA with roughly 6.2 percent stake. The investment vehicle is interested in two board seats at time when two directors are expected to stand for reelection. The board of ARIA has eight members. After investor booked profits over the past days, shares of <b>Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)<\/b> are back on the green zone, gaining more than 1.51 percent in the previous session to finish at $8.73.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 02\/20\/2014 (wallstreetpr) &#8211;\u00a0Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) could soon be without the services of its billionaire chairman Philip Frost if reports appearing [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":14450,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[2780,4676,2781,4677,2457,1601,2063,4029,2456,4675,4674,4028],"stock_ticker":[],"class_list":["post-15736","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-ariad-pharmaceuticals-inc-nasdaqaria","tag-ladenburg-thalmann-financial-services-nyselts","tag-nasdaqaria","tag-nyselts","tag-nyseoibr","tag-nyseopk","tag-nysetef","tag-nyseteva","tag-oi-sa-adr-nyseoibr","tag-opko-health-nyseopk","tag-telefonica-s-a-adr-nysetef","tag-teva-pharmaceutical-industries-ltd-adr-nyseteva","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 02\/20\/2014 (wallstreetpr) &#8211;\u00a0Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) could soon be without the services of its billionaire chairman Philip Frost if reports appearing [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-21T14:05:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)\",\"datePublished\":\"2014-02-21T14:05:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736\"},\"wordCount\":376,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"keywords\":[\"Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)\",\"Ladenburg Thalmann Financial Services (NYSE:LTS)\",\"NASDAQ:ARIA\",\"NYSE:LTS\",\"NYSE:OIBR\",\"NYSE:OPK\",\"NYSE:TEF\",\"NYSE:TEVA\",\"Oi SA ADR (NYSE:OIBR)\",\"Opko Health (NYSE:OPK)\",\"Telefonica S.A. (ADR) (NYSE:TEF)\",\"Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736\",\"name\":\"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"datePublished\":\"2014-02-21T14:05:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"width\":1024,\"height\":709},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736","og_locale":"en_US","og_type":"article","og_title":"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) - Wall Street PR","og_description":"Boston, MA 02\/20\/2014 (wallstreetpr) &#8211;\u00a0Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) could soon be without the services of its billionaire chairman Philip Frost if reports appearing [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-02-21T14:05:37+00:00","og_image":[{"width":1024,"height":709,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)","datePublished":"2014-02-21T14:05:37+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736"},"wordCount":376,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","keywords":["Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)","Ladenburg Thalmann Financial Services (NYSE:LTS)","NASDAQ:ARIA","NYSE:LTS","NYSE:OIBR","NYSE:OPK","NYSE:TEF","NYSE:TEVA","Oi SA ADR (NYSE:OIBR)","Opko Health (NYSE:OPK)","Telefonica S.A. (ADR) (NYSE:TEF)","Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736","url":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736","name":"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","datePublished":"2014-02-21T14:05:37+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","width":1024,"height":709},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/stocks-on-the-spotlight-teva-pharmaceutical-industries-ltd-adr-nyseteva-oi-sa-adr-nyseoibr-ariad-pharmaceuticals-inc-nasdaqaria-15736#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/15736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=15736"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/15736\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/14450"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=15736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=15736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=15736"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=15736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}